(19)
(11) EP 4 584 250 A1

(12)

(43) Date of publication:
16.07.2025 Bulletin 2025/29

(21) Application number: 23863939.7

(22) Date of filing: 06.09.2023
(51) International Patent Classification (IPC): 
C07D 235/30(2006.01)
A61P 25/24(2006.01)
A61K 31/4168(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 25/24; A61K 45/06
 
C-Sets:
  1. A61K 31/47, A61K 2300/00;
  2. A61K 31/27, A61K 2300/00;
  3. A61K 31/428, A61K 2300/00;
  4. A61K 31/4184, A61K 2300/00;

(86) International application number:
PCT/US2023/073504
(87) International publication number:
WO 2024/054811 (14.03.2024 Gazette 2024/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 06.09.2022 US 202263403911 P

(71) Applicant: Biohaven Therapeutics Ltd.
Tortola VG1110 (VG)

(72) Inventors:
  • CORIC, Vladimir
    New Haven, CT 06510 (US)
  • DWORETZKY, Steven I.
    New Haven, CT 06510 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS